Shares of Medtronic PLC MDT slipped 1.90% to $91.51 Wednesday, on what proved to be an all-around mixed trading session for ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc, a global leader in healthcare technology, proudly announces U.S. Food and Drug Administration ...

Citi analyst Joanne Wuensch upgraded Medtronic (MDT) to Buy from Neutral with a price target of $107, up from $92. The stock initially fell 7% ...

Shares of Medtronic PLC MDT rallied 1.47% to $94.50 Friday, on what proved to be an all-around positive trading session for ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...

Medtronic is a diversified medical device maker with a global footprint. Its reliably growing dividend has helped fuel its stock performance for decades. Its shares are reasonably valued for the ...

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business.

Medtronic (NYSE:MDT) traded lower in pre-market hours Tuesday, down 4.54% to $88.60 as of 08:20 AM ET, despite reaffirming its full-year guidance alongside its Q3 FY25 results. The MedTech giant ...

5 analysts have expressed a variety of opinions on Medtronic MDT over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...